$BCTX The external Data Safety Monitoring Board (DSMB) has completed its second safety data review of BriaCell’s pivotal Phase 3 study in #metastaticbreastcancer and recommended continuation of the ongoing study without any modifications.
https://bit.ly/4hiTYoQ $BCTX $BCTXW